SEC INSIDER TRANSACTIONS

Reddit, Inc. (RDDT) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

RDDT · Reddit, Inc.

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Active filters: days=6m

Stale snapshot · Covered: filings 2026-05-14 to 2026-11-13 · 52 filings · fetched 2026-11-13T19:39:18Z

Recent reported activity

0purchase rows on this page

20sale rows on this page

221matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-11-06Filed 2026-11-10	Gale Mary PorterDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Class A Common Stock · Non-derivative	4,000D	96	IndirectThe Gale Trust	Form 4 ↗0001924581-26-000011
2026-11-04Filed 2026-11-05	Gale Mary PorterDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Class A Common Stock · Non-derivative	3,000D	100	IndirectThe Gale Trust	Form 4 ↗0001924581-26-000009
2026-11-03Filed 2026-11-05	Gale Mary PorterDirector Filing context Reported filing row; may be amended. Do not sum filings blindly. References:	S Sale (market/private)Class A Common Stock · Non-derivative	3,000D	96	IndirectThe Gale Trust	Form 4 ↗0001924581-26-000009
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F11	M Exercise / conversionStock Option (Right to Buy) · Derivative	14,563D	0	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F10	M Exercise / conversionStock Option (Right to Buy) · Derivative	45,437D	0	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F9	S Sale (market/private)Class A Common Stock · Non-derivative	1,361D	155.91	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F8	S Sale (market/private)Class A Common Stock · Non-derivative	1,639D	154.88	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F7	S Sale (market/private)Class A Common Stock · Non-derivative	2,100D	154.03	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F6	S Sale (market/private)Class A Common Stock · Non-derivative	5,701D	152.82	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F5	S Sale (market/private)Class A Common Stock · Non-derivative	5,495D	152.14	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F4	S Sale (market/private)Class A Common Stock · Non-derivative	11,200D	150.87	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F3	S Sale (market/private)Class A Common Stock · Non-derivative	6,399D	150.08	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1, F2	S Sale (market/private)Class A Common Stock · Non-derivative	26,105D	148.86	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1	M Exercise / conversionClass A Common Stock · Non-derivative	14,563A	25.29	Direct	Form 4 ↗0001663651-26-000023
2026-10-14Filed 2026-10-16	Wong Jennifer L.Officer · Chief Operating Officer Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2026. F2 The sales were executed in multiple trades at prices ranging from $148.50 to $149.49. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 9 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $149.50 to $150.49. F4 The sales were executed in multiple trades at prices ranging from $150.50 to $151.38. F5 The sales were executed in multiple trades at prices ranging from $151.51 to $152.49. F6 The sales were executed in multiple trades at prices ranging from $152.51 to $153.43. F7 The sales were executed in multiple trades at prices ranging from $153.54 to $154.47. F8 The sales were executed in multiple trades at prices ranging from $154.54 to $155.47. F9 The sales were executed in multiple trades at prices ranging from $155.55 to $156.31. F10 The stock option is fully vested and currently exercisable. F11 The option vests over five years on each quarterly anniversary of December 25, 2023. References: F1	M Exercise / conversionClass A Common Stock · Non-derivative	45,437A	20.76	Direct	Form 4 ↗0001663651-26-000023
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F12	M Exercise / conversionStock Option (Right to Buy) · Derivative	17,308D	0	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F10	S Sale (market/private)Class A Common Stock · Non-derivative	500D	163.72	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F9	S Sale (market/private)Class A Common Stock · Non-derivative	700D	162.8	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F8	S Sale (market/private)Class A Common Stock · Non-derivative	1,700D	161.98	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F7	S Sale (market/private)Class A Common Stock · Non-derivative	1,800D	160.95	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F6	S Sale (market/private)Class A Common Stock · Non-derivative	1,200D	159.76	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F5	S Sale (market/private)Class A Common Stock · Non-derivative	2,500D	158.84	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F4	S Sale (market/private)Class A Common Stock · Non-derivative	4,200D	157.61	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F3	S Sale (market/private)Class A Common Stock · Non-derivative	1,300D	156.47	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043
2026-10-13Filed 2026-10-15	Huffman Steve LaddDirector · Officer · Ten-percent owner · CEO & President Filing context Reported filing row; may be amended. Do not sum filings blindly. F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 The sales were executed in multiple trades at prices ranging from $155.06 to $155.99. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4. F3 The sales were executed in multiple trades at prices ranging from $156.07 to $156.95. F4 The sales were executed in multiple trades at prices ranging from $157.10 to $158.03. F5 The sales were executed in multiple trades at prices ranging from $158.37 to $159.34. F6 The sales were executed in multiple trades at prices ranging from $159.42 to $160.16. F7 The sales were executed in multiple trades at prices ranging from $160.44 to $161.35. F8 The sales were executed in multiple trades at prices ranging from $161.47 to $162.43. F9 The sales were executed in multiple trades at prices ranging from $162.47 to $163.18. F10 The sales were executed in multiple trades at prices ranging from $163.47 to $164.04. F11 The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary. F12 The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. References: F1, F2	S Sale (market/private)Class A Common Stock · Non-derivative	3,408D	155.33	IndirectBy The XYZ Revocable Trust	Form 4 ↗0001827011-26-000043

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.